Skip links

Oxymetazoline Hydrochloride

Home / API - Commercial / Oxymetazoline Hydrochloride
Oxymetazoline Hydrochloride API manufacturer & supplier
CAS No.
2315-02-8
Therapeutic Category
Innovator Brand
NASIVIN , AFRIN , ILIADIN
GMP
Available
DMF
Available
Filed
USDMF AssessedCEPNMPAKFDAMOH Russia
Under Filing
-
Sample
Available
Indication

Oxymetazoline known under Brandname NASIVIN, AFRIN or ILIADIN, is indicated for the topical treatment of persistent facial erythema associated with rosacea in adults. Ophthalmic oxymetazoline is indicated for the treatment of acquired blepharoptosis in adults.

 

CTX Lifesciences, is one of the leading Active Pharmaceutical Ingredients ( API ) manufacturer and supplier globally for Oxymetazoline Hydrochloride ( HCl ) with CAS Number:2315-02-8. We are a leading exporter of  Oxymetazoline Hydrochloride ( HCl ) with CAS Number:2315-02-8. We are a trusted supplier with API exports in more than 87 Countries including the US, Europe, Brazil, Latin America,  China, Korea,Iran, Middle East and other emerging markets.

 

CTX Lifesciences is one of the leading API manufacturer & supplier of  Oxymetazoline Hydrochloride ( HCl ) with CAS Number:2315-02-8. This product is provided from our GMP compliant plant with product made under complete cGMP conditions. We provided with documentation support Drug Master File ( DMF ). Our manufacturing plant at Surat,India has accreditation by US-FDA, EDQM, EMA, ANVISA, KFDA, MOH-IRAN, Health Canada & Russian Authorities.

 

Oxymetazoline, sold under the brand name Afrin among others, is a topical decongestant and vasoconstrictor medication. It is available over-the-counter as a nasal spray to treat nasal congestion and nosebleeds, as eyedrops to treat eye redness due to minor irritation, and (in the United States) as a prescription topical cream to treat persistent facial redness due to rosacea in adults.

 

CTX also offer another imidazole derivative for similar end use i.e Xylometazoline HCl.

Disclaimer: CTX Lifesciences respects patent laws and conventions of pharmaceuticals as applicable in different countries.
API/Substances covered by patent are not offered to the countries where the patent law is in force. However, the final responsibility lies with the customer.

Send Enquiry